136 related articles for article (PubMed ID: 37598478)
61. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS
Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442
[TBL] [Abstract][Full Text] [Related]
62. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
63. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
64. IL-6 expression promoted by Poly(I:C) in cervical cancer cells regulates cytokine expression and recruitment of macrophages.
Liu X; Meng L; Chen L; Liang Y; Wang B; Shao Q; Wang H; Yang X
J Cell Mol Med; 2020 Feb; 24(3):2284-2293. PubMed ID: 31943744
[TBL] [Abstract][Full Text] [Related]
65. Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancer.
Zhang Y; Li J; Yang F; Zhang X; Ren X; Wei F
J Leukoc Biol; 2022 Dec; 112(6):1591-1603. PubMed ID: 35501298
[TBL] [Abstract][Full Text] [Related]
66. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome.
Agostini C; Trentin L; Sancetta R; Facco M; Tassinari C; Cerutti A; Bortolin M; Milani A; Siviero M; Zambello R; Semenzato G
Blood; 1997 Aug; 90(3):1115-23. PubMed ID: 9242543
[TBL] [Abstract][Full Text] [Related]
67. Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway.
Wang H; Xie X; Lu WG; Ye DF; Chen HZ; Li X; Cheng Q
Life Sci; 2004 Feb; 74(14):1739-49. PubMed ID: 14741732
[TBL] [Abstract][Full Text] [Related]
68. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
69. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.
Morgan EL; Scarth JA; Patterson MR; Wasson CW; Hemingway GC; Barba-Moreno D; Macdonald A
Cell Death Differ; 2021 May; 28(5):1669-1687. PubMed ID: 33303976
[TBL] [Abstract][Full Text] [Related]
70. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
Luna DE; Shinohara MM
Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872
[TBL] [Abstract][Full Text] [Related]
71. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
Castagnino P; Kim HW; Lam LKM; Basu D; White EA
J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
[TBL] [Abstract][Full Text] [Related]
72. Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells.
Russell MA; Cooper AC; Dhayal S; Morgan NG
Islets; 2013; 5(2):95-105. PubMed ID: 23510983
[TBL] [Abstract][Full Text] [Related]
73. The Role of IL-33/ST2 Pathway in Tumorigenesis.
Larsen KM; Minaya MK; Vaish V; Peña MMO
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
[TBL] [Abstract][Full Text] [Related]
74. Efficient internalization of IL-2 depends on the distal portion of the cytoplasmic tail of the IL-2R common gamma-chain and a lymphoid cell environment.
Yu A; Olosz F; Choi CY; Malek TR
J Immunol; 2000 Sep; 165(5):2556-62. PubMed ID: 10946282
[TBL] [Abstract][Full Text] [Related]
75. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
76. Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17
Su Y; Wang Q; Yang B; Wu L; Cheng G; Kuang H
Clin Exp Immunol; 2017 Oct; 190(1):40-53. PubMed ID: 28617942
[TBL] [Abstract][Full Text] [Related]
77. Interleukin-6 and Interferon-α Signaling
Danziger O; Pupko T; Bacharach E; Ehrlich M
Front Immunol; 2018; 9():94. PubMed ID: 29441069
[TBL] [Abstract][Full Text] [Related]
78. Biology of the interleukin-2 receptor.
Nelson BH; Willerford DM
Adv Immunol; 1998; 70():1-81. PubMed ID: 9755337
[TBL] [Abstract][Full Text] [Related]
79. JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells.
Yamada O; Ozaki K; Akiyama M; Kawauchi K
Mol Cancer Ther; 2012 May; 11(5):1112-21. PubMed ID: 22402124
[TBL] [Abstract][Full Text] [Related]
80. Human papilloma virus (HPV) and cervical cancer.
Furumoto H; Irahara M
J Med Invest; 2002 Aug; 49(3-4):124-33. PubMed ID: 12323001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
